Ghana-Press-Review February 23, 2021 to 09:25 486 APA – Accra (Ghana) The assurance by the Food and Drugs Authority (FDA) that adequate safety and quality assurance has been done in authorising the two COVID-19 vaccines to be administered in Ghana is one of the trending stories in the Ghanaian press on Tuesday.
The Graphic reports that the Food and Drugs Authority (FDA) says adequate safety and quality assurance has been done in authorising the two COVID-19 vaccines to be administered in the country.
It said no safety and efficacy standards were bypassed or compromised, except that the emergency use authorisation pathway allowed for expedited review for the public good.
705
The Food and Drugs Authority (FDA) says adequate safety and quality assurance has been done in authorising the two COVID-19 vaccines to be administered in the country.
It said no safety and efficacy standards were bypassed or compromised, except that the emergency use authorisation pathway allowed for expedited review for the public good.
Assurance
Giving the assurance in an interview with the Daily Graphic in Accra yesterday, the Chief Executive Officer (CEO) of the FDA, Mrs Delese Mimi Darko, said the two vaccines were Covishield, AstraZeneca Vaccine, manufactured by Serum Institute of India, and Sputnik-V, manufactured by Generium in Russia.
2021/01/11 09:17 Packaging for Sinopharm vaccine. (CNA photo) Packaging for Sinopharm vaccine. (CNA photo) TAIPEI (Taiwan News) Amid increasing concern about the efficacy and safety of China s Wuhan coronavirus vaccines, the full list of the adverse side effects of the Sinopharm jab surfaced last week. Shanghai-based vaccine expert Tao Lina (陶黎納) on Jan. 4 uploaded to Weibo a digital version of the manual for BBIBP-CorV, an inactivated vaccine produced by China National Biotec Group (CNBG), a subsidiary of China National Pharmaceutical Group Corporation (Sinopharm). In his post, he described the vaccine as the most unsafe vaccine in the world due to its 73 local and systemic adverse reactions.